Pre-eclampsia part 1: current understanding of its pathophysiology (original) (raw)

• Lindheimer, M. D., Roberts, J. M., Cunningham, G. C. & Chesley, L. in Chesley's Hypertensive Disorders in Pregnancy (eds Lindheimer, M. D., Roberts, J. M. & Cunningham, G. C.), 1–24 (Elsevier, 2009).
  Book Google Scholar
• Romero, R., Lockwood, C., Oyarzun, E. & Hobbins, J. C. Toxemia: new concepts in an old disease. Semin. Perinatol. 12, 302–323 (1988).
  CAS PubMed Google Scholar
• Redman, C. W. & Sargent, I. L. Latest advances in understanding preeclampsia. Science 308, 1592–1594 (2005).
  Article CAS PubMed Google Scholar
• Roberts, J. M. & Gammill, H. S. Preeclampsia: recent insights. Hypertension 46, 1243–1249 (2005).
  Article CAS PubMed Google Scholar
• Sibai, B., Dekker, G. & Kupferminc, M. Pre-eclampsia. Lancet 365, 785–799 (2005).
  Article PubMed Google Scholar
• Steegers, E. A., von Dadelszen, P., Duvekot, J. J. & Pijnenborg, R. Pre-eclampsia. Lancet 376, 631–644 (2010).
  Article PubMed Google Scholar
• American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy, Hypertension in Pregnancy [online], (2013).
• Lowe, S. A. et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust. NZ J. Obstet. Gynaecol. 49, 242–246 (2009).
  Article Google Scholar
• Hutcheon, J. A., Lisonkova, S. & Joseph, K. S. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol. 25, 391–403 (2011).
  Article PubMed Google Scholar
• Thornton, C., Dahlen, H., Korda, A. & Hennessy, A. The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000–2008 Am. J. Obstet. Gynecol. 208, 476 e471–e475 (2013).
  Article PubMed Google Scholar
• Adu-Bonsaffoh, K., Samuel, O. A. & Binlinla, G. Maternal deaths attributable to hypertensive disorders in a tertiary hospital in Ghana. Int. J. Gynaecol Obstet. 123, 110–113 (2013).
  Article PubMed Google Scholar
• Acosta-Sison, H. The relationship of hydatidiform mole to pre-eclampsia and eclampsia; a study of 85 cases. Am. J. Obstet. Gynecol. 71, 1279–1282 (1956).
  Article CAS PubMed Google Scholar
• Young, J. The aetiology of eclampsia and albuminuria and their relation to accidental haemorrhage: (an anatomical and experimental investigation.). Proc. R. Soc. Med. 7, 307–348 (1914).
  PubMed PubMed Central Google Scholar
• Page, E. W. On the pathogenesis of pre-eclampsia and eclampsia. J. Obstet. Gynaecol Br. Commonw. 79, 883–894 (1972).
  Article CAS PubMed Google Scholar
• Rodgers, G. M., Taylor, R. N. & Roberts, J. M. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am. J. Obstet. Gynecol. 159, 908–914 (1988).
  Article CAS PubMed Google Scholar
• Roberts, J. M., Edep, M. E., Goldfien, A. & Taylor, R. N. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence. Am. J. Reprod. Immunol. 27, 101–108 (1992).
  Article CAS PubMed Google Scholar
• Sacks, G. P., Studena, K., Sargent, K. & Redman, C. W. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol. 179, 80–86 (1998).
  Article CAS PubMed Google Scholar
• Redman, C. W., Sacks, G. P. & Sargent, I. L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 180, 499–506 (1999).
  Article CAS PubMed Google Scholar
• Gervasi, M. T. et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am. J. Obstet. Gynecol. 185, 792–797 (2001).
  Article CAS PubMed Google Scholar
• Kenny, L. C., Baker, P. N. & Cunningham, F. G. in Chesley's Hypertensive Disorders in Pregnancy (eds Lindheimer, M. D., Roberts, J. M. & Cunningham, G. C.) 335–351 (Elsevier, 2009).
  Book Google Scholar
• Lindheimer, M. D., Roberts, J. M., Cunningham, G. C. & Chesley, L. in Chesley's Hypertensive Disorders in Pregnancy (eds Lindheimer, M. D., Roberts, J. M. & Cunningham, G. C.) 25–36 (Elsevier, 2009).
  Google Scholar
• Chaiworapongsa, T., Chaemsaithong, P., Korzeniewski, S. J., Yeo, L. & Romero, R. Pre-eclampsia part 2: prediction, prevention and management. Nat. Rev. Nephrol. http://dx.doi.org/10.1038/nrneph.2014.103.
• Lindheimer, M. D. W. Benson and Pamela Harer Seminar on History. The History of Preeclampsia and Eclampsia as Seen by a Nephrologist (2012).
  Google Scholar
• Lever, J. C. Cases of puerperal convulsions with remarks. Guys Hosp. Rep. 2, 495–517 (1843).
  Google Scholar
• Ballantyne, J. W. Sphygmographic tracings in puerperal eclampsia. Edinburgh Med. J. 30, 1007–1020 (1885).
  Google Scholar
• Ballantyne, J. W. A plea for a pro-maternity hospital. Br. Med. J. 1, 813–814 (1901).
  Article CAS PubMed PubMed Central Google Scholar
• Redman, C. W. & Sargent, I. L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 63, 534–543 (2010).
  Article CAS PubMed Google Scholar
• Dekker, G., Robillard, P. Y. & Roberts, C. The etiology of preeclampsia: the role of the father. J. Reprod. Immunol. 89, 126–132 (2011).
  Article PubMed Google Scholar
• Chesley, L. C., Annitto, J. E. & Cosgrove, R. A. The familial factor in toxemia of pregnancy. Obstet. Gynecol. 32, 303–311 (1968).
  CAS PubMed Google Scholar
• Thornton, J. G. & Macdonald, A. M. Twin mothers, pregnancy hypertension and pre-eclampsia. Br. J. Obstet. Gynaecol. 106, 570–575 (1999).
  Article CAS PubMed Google Scholar
• Goddard, K. A. et al. Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum. Hered. 63, 1–16 (2007).
  Article CAS PubMed Google Scholar
• Parimi, N. et al. Analytical approaches to detect maternal/fetal genotype incompatibilities that increase risk of pre-eclampsia. BMC Med. Genet. 9, 60 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Ward, K. & Lindheimer, M. D. in Chesley's Hypertensive Disorders in Pregnancy (eds Lindheimer, M. D., Roberts, J. M. & Cunningham, G. C.) 51–71 (Elsevier, 2009).
  Book Google Scholar
• Zhao, L., Bracken, M. B., Dewan, A. T. & Chen, S. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis. Mol. Hum. Reprod. 19, 136–143 (2013).
  Article CAS PubMed Google Scholar
• Zhao, L. et al. Genome-wide association study identifies a maternal copy-number deletion in PSG11 enriched among preeclampsia patients. BMC Pregnancy Childbirth 12, 61 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Morgan, M. A. & Thurnau, G. R. Pregnancy-induced hypertension without proteinuria: is it true preeclampsia? South. Med. J. 81, 210–213 (1988).
  Article CAS PubMed Google Scholar
• Barton, J. R., O'Brien, J. M., Bergauer, N. K., Jacques, D. L. & Sibai, B. M. Mild gestational hypertension remote from term: progression and outcome. Am. J. Obstet. Gynecol. 184, 979–983 (2001).
  Article CAS PubMed Google Scholar
• Homer, C. S., Brown, M. A., Mangos, G. & Davis, G. K. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J. Hypertens. 26, 295–302 (2008).
  Article CAS PubMed Google Scholar
• Lindheimer, M. D. & Kanter, D. Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach. Obstet. Gynecol. 115, 365–375 (2010).
  Article CAS PubMed Google Scholar
• Meyer, N. L., Mercer, B. M., Friedman, S. A. & Sibai, B. M. Urinary dipstick protein: a poor predictor of absent or severe proteinuria. Am. J. Obstet. Gynecol. 170, 137–141 (1994).
  Article CAS PubMed Google Scholar
• Kuo, V. S., Koumantakis, G. & Gallery, E. D. Proteinuria and its assessment in normal and hypertensive pregnancy. Am. J. Obstet. Gynecol. 167, 723–728 (1992).
  Article CAS PubMed Google Scholar
• Lindow, S. W. & Davey, D. A. The variability of urinary protein and creatinine excretion in patients with gestational proteinuric hypertension. Br. J. Obstet. Gynaecol. 99, 869–872 (1992).
  Article CAS PubMed Google Scholar
• Verdonk, K. et al. Variation of urinary protein to creatinine ratio during the day in women with suspected pre-eclampsia. BJOG http://dx.doi.org/10.1111/1471-0528.12803.
• Cote, A. M. et al. Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review. BMJ 336, 1003–1006 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Thangaratinam, S. et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med. 7, 10 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Goodlin, R. C. Severe pre-eclampsia: another great imitator. Am. J. Obstet. Gynecol. 125, 747–753 (1976).
  Article CAS PubMed Google Scholar
• Weinstein, L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am. J. Obstet. Gynecol. 142, 159–167 (1982).
  Article CAS PubMed Google Scholar
• Romero, R. et al. Clinical significance of liver dysfunction in pregnancy-induced hypertension. Am. J. Perinatol. 5, 146–151 (1988).
  Article CAS PubMed Google Scholar
• Romero, R. et al. Clinical significance, prevalence, and natural history of thrombocytopenia in pregnancy-induced hypertension. Am. J. Perinatol. 6, 32–38 (1989).
  Article CAS PubMed Google Scholar
• Sibai, B. M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet. Gynecol. 103, 981–991 (2004).
  Article PubMed Google Scholar
• von Dadelszen, P., Magee, L. A. & Roberts, J. M. Subclassification of preeclampsia. Hypertens. Pregnancy 22, 143–148 (2003).
  Article PubMed Google Scholar
• Crispi, F. et al. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet. Gynecol. 31, 303–309 (2008).
  Article CAS PubMed Google Scholar
• Soto, E. et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J. Matern. Fetal Neonatal Med. 25, 498–507 (2012).
  Article CAS PubMed Google Scholar
• Parra-Cordero, M. et al. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy. Ultrasound Obstet. Gynecol. 41, 538–544 (2013).
  Article CAS PubMed Google Scholar
• Ogge, G. et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J. Perinat. Med. 39, 641–652 (2011).
  Article PubMed PubMed Central Google Scholar
• Sibai, B. M. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am. J. Obstet. Gynecol. 205, 191–198 (2011).
  Article PubMed Google Scholar
• Ogden, E., Hildebrand, G. J. & Page, E. W. Rise of blood pressure during ischemia of gravid uterus. Proc. Soc. Exp. Bio Med. 43, 49–51 (1940).
  Article Google Scholar
• Lunell, N. O., Nylund, L. E., Lewander, R. & Sarby, B. Uteroplacental blood flow in pre-eclampsia measurements with indium-113m and a computer-linked gamma camera. Clin. Exp. Hypertens. B 1, 105–117 (1982).
  CAS PubMed Google Scholar
• Brosens, I., Robertson, W. B. & Dixon, H. G. The physiological response of the vessels of the placental bed to normal pregnancy. J. Pathol. Bacteriol. 93, 569–579 (1967).
  Article CAS PubMed Google Scholar
• Brosens, I. & Renaer, M. On the pathogenesis of placental infarcts in pre-eclampsia. J. Obstet. Gynaecol Br. Commonw. 79, 794–799 (1972).
  Article CAS PubMed Google Scholar
• Hertig, A. T. Vascular pathology in hypertensive albuminuric toxemias of pregnancy. Clinics 4, 1011–1015 (1945).
  Google Scholar
• De Wolf, F., Robertson, W. B. & Brosens, I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am. J. Obstet. Gynecol. 123, 164–174 (1975).
  Article CAS PubMed Google Scholar
• Robertson, W. B., Brosens, I. & Dixon, H. G. The pathological resonse of the vessels of the placental bed to hypertensive pregnancy. J. Pathol. Bacteriol. 93, 581–592 (1967).
  Article CAS PubMed Google Scholar
• Labarrere, C. A. Acute atherosis. A histopathological hallmark of immune aggression? Placenta 9, 95–108 (1988).
  Article CAS PubMed Google Scholar
• Staff, A. C., Dechend, R. & Redman, C. W. Review: Preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses. Placenta 34 (Suppl.), S73–S78 (2013).
  Article PubMed Google Scholar
• Brosens, I., Pijnenborg, R., Vercruysse, L. & Romero, R. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am. J. Obstet. Gynecol. 204, 193–201 (2011).
  Article PubMed Google Scholar
• Khong, T. Y., Liddell, H. S. & Robertson, W. B. Defective haemochorial placentation as a cause of miscarriage: a preliminary study. Br. J. Obstet. Gynaecol. 94, 649–655 (1987).
  Article CAS PubMed Google Scholar
• Ball, E., Bulmer, J. N., Ayis, S., Lyall, F. & Robson, S. C. Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J. Pathol. 208, 535–542 (2006).
  Article CAS PubMed Google Scholar
• Brosens, I. A., Robertson, W. B. & Dixon, H. G. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet. Gynecol. Annu. 1, 177–191 (1972).
  CAS PubMed Google Scholar
• Khong, T. Y., De Wolf, F., Robertson, W. B. & Brosens, I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br. J. Obstet. Gynaecol. 93, 1049–1059 (1986).
  Article CAS PubMed Google Scholar
• Dommisse, J. & Tiltman, A. J. Placental bed biopsies in placental abruption. Br. J. Obstet. Gynaecol. 99, 651–654 (1992).
  Article CAS PubMed Google Scholar
• Kim, Y. M. et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am. J. Obstet. Gynecol. 189, 1063–1069 (2003).
  Article PubMed Google Scholar
• Kim, Y. M. et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am. J. Obstet. Gynecol. 187, 1137–1142 (2002).
  Article PubMed Google Scholar
• Pijnenborg, R. & Brosens, I. in Placental Bed Disorders: Basic Science and its Translation to Obstetrics (eds Pijnenborg, R., Brosens, I. & Romero, R.) 97–108 (Cambridge University Press, 2010).
  Book Google Scholar
• Zhou, Y., Damsky, C. H. & Fisher, S. J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J. Clin. Invest. 99, 2152–2164 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Rosenfeld, C. R., Roy, T. & Cox, B. E. Mechanisms modulating estrogen-induced uterine vasodilation. Vascul. Pharmacol. 38, 115–125 (2002).
  Article CAS PubMed Google Scholar
• Osol, G. & Moore, L. G. Maternal uterine vascular remodeling during pregnancy. Microcirculation 21, 38–47 (2014).
  Article PubMed Google Scholar
• Burton, G. J., Watson, A. L., Hempstock, J., Skepper, J. N. & Jauniaux, E. Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J. Clin. Endocrinol. Metab. 87, 2954–2959 (2002).
  Article CAS PubMed Google Scholar
• Burton, G. J., Hempstock, J. & Jauniaux, E. Nutrition of the human fetus during the first trimester—a review. Placenta 22 (Suppl. A), S70–S77 (2001).
  Article PubMed Google Scholar
• Jauniaux, E. et al. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am. J. Pathol. 157, 2111–2122 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Genbacev, O., Joslin, R., Damsky, C. H., Polliotti, B. M. & Fisher, S. J. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J. Clin. Invest. 97, 540–550 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Caniggia, I. et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ(3). J. Clin. Invest. 105, 577–587 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Rajakumar, A., Brandon, H. M., Daftary, A., Ness, R. & Conrad, K. P. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta 25, 763–769 (2004).
  Article CAS PubMed Google Scholar
• Tal, R. et al. Effects of hypoxia-inducible factor-1α overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction. Am. J. Pathol. 177, 2950–2962 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kanasaki, K. et al. Deficiency in catechol-_O_-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 453, 1117–1121 (2008).
  Article CAS PubMed Google Scholar
• Palmer, K. et al. Severe early-onset preeclampsia is not associated with a change in placental catechol _O_-methyltransferase (COMT) expression. Am. J. Pathol. 178, 2484–2488 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Seol, H. J., Cho, G. J., Oh, M. J. & Kim, H. J. 2-methoxyoestradiol levels and placental catechol-_O_-methyltransferase expression in patients with late-onset preeclampsia. Arch. Gynecol. Obstet. 287, 881–886 (2013).
  Article CAS PubMed Google Scholar
• Redman, C. W. & Sargent, I. L. Placental stress and pre-eclampsia: a revised view. Placenta 30 (Suppl. A), S38–S42 (2009).
  Article PubMed CAS Google Scholar
• Brosens, J. J., Parker, M. G., McIndoe, A., Pijnenborg, R. & Brosens, I. A. A role for menstruation in preconditioning the uterus for successful pregnancy. Am. J. Obstet. Gynecol. 200, 615.e1–615.e6 (2009).
  Article Google Scholar
• Moffett, A. & Hiby, S. E. How does the maternal immune system contribute to the development of preeclampsia? Placenta 28 (Suppl. A), S51–S56 (2007).
  Article PubMed CAS Google Scholar
• Zhang, K. & Kaufman, R. J. From endoplasmic-reticulum stress to the inflammatory response. Nature 454, 455–462 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Burton, G. J., Yung, H. W., Cindrova-Davies, T. & Charnock-Jones, D. S. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 30 (Suppl. A), S43–S48 (2009).
  Article PubMed CAS Google Scholar
• Huppertz, B., Kadyrov, M. & Kingdom, J. C. Apoptosis and its role in the trophoblast. Am. J. Obstet. Gynecol. 195, 29–39 (2006).
  Article PubMed Google Scholar
• Redman, C. W. & Sargent, I. L. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J. Reprod. Immunol. 76, 61–67 (2007).
  Article CAS PubMed Google Scholar
• Lian, I. A. et al. Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without pre-eclampsia. Placenta 32, 823–829 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Burton, G. J. & Jauniaux, E. Oxidative stress. Best Pract Res. Clin. Obstet. Gynaecol. 25, 287–299 (2011).
  Article PubMed PubMed Central Google Scholar
• Cindrova-Davies, T., Spasic-Boskovic, O., Jauniaux, E., Charnock-Jones, D. S. & Burton, G. J. Nuclear factor-κB, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins. Am. J. Pathol. 170, 1511–1520 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Martin, C. B. Jr, McGaughey, H. S. Jr, Kaiser, I. H., Donner, M. W. & Ramsey, E. M. Intermittent functioning of the uteroplacental arteries. Am. J. Obstet. Gynecol. 90, 819–823 (1964).
  Article PubMed Google Scholar
• Burton, G. J., Woods, A. W., Jauniaux, E. & Kingdom, J. C. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30, 473–482 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Many, A., Hubel, C. A., Fisher, S. J., Roberts, J. M. & Zhou, Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am. J. Pathol. 156, 321–331 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Vaughan, J. E. & Walsh, S. W. Oxidative stress reproduces placental abnormalities of preeclampsia. Hypertens. Pregnancy 21, 205–223 (2002).
  Article CAS PubMed Google Scholar
• George, E. M. & Granger, J. P. Heme oxygenase in pregnancy and preeclampsia. Curr. Opin. Nephrol. Hypertens. 22, 156–162 (2013).
  Article CAS PubMed Google Scholar
• Zhao, H., Wong, R. J., Kalish, F. S., Nayak, N. R. & Stevenson, D. K. Effect of heme oxygenase-1 deficiency on placental development. Placenta 30, 861–868 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Nakamura, M. et al. Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women. Prenat Diagn. 29, 691–696 (2009).
  Article CAS PubMed Google Scholar
• Lash, G. E. et al. Relationship between tissue damage and heme oxygenase expression in chorionic villi of term human placenta. Am. J. Physiol. Heart Circ. Physiol. 284, H160–H167 (2003).
  Article CAS PubMed Google Scholar
• Farina, A. et al. Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. Prenat. Diagn. 28, 956–961 (2008).
  Article PubMed Google Scholar
• George, E. M. et al. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 57, 941–948 (2011).
  Article CAS PubMed Google Scholar
• Costantine, M. M. et al. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia. Obstet. Gynecol. 116, 114–120 (2010).
  Article CAS PubMed Google Scholar
• Gant, N. F., Chand, S., Whalley, P. J. & MacDonald, P. C. The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet. Gynecol. 43, 854 (1974).
  CAS PubMed Google Scholar
• Dechend, R., Luft, F. C. & Lindheimer, M. in Chesley's Hypertensive Disorders in Pregnancy (eds Lindheimer, M. D., Roberts, J. M. & Cunningham, G. C.) 287–296 (Elsevier, 2009).
  Book Google Scholar
• Wallukat, G. et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 103, 945–952 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Dechend, R. et al. Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension 45, 742–746 (2005).
  Article CAS PubMed Google Scholar
• Zhou, C. C. et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 14, 855–862 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Parrish, M. R. et al. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am. J. Hypertens. 23, 911–916 (2010).
  Article CAS PubMed Google Scholar
• Xia, Y. & Kellems, R. E. Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond. Circ. Res. 113, 78–87 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Li, J., LaMarca, B. & Reckelhoff, J. F. A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am. J. Physiol. Heart Circ. Physiol. 303, H1–H8 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Dhillion, P. et al. IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am. J. Physiol. Regul. Integr Comp. Physiol. 303, R353–R358 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Girardi, G., Yarilin, D., Thurman, J. M., Holers, V. M. & Salmon, J. E. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J. Exp. Med. 203, 2165–2175 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Herse, F. & LaMarca, B. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. Am. J. Reprod. Immunol. 69, 413–418 (2013).
  Article CAS PubMed Google Scholar
• Novotny, S. R. et al. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am. J. Physiol. Regul. Integr Comp. Physiol. 302, R1197–1201 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Herse, F. et al. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 53, 393–398 (2009).
  Article CAS PubMed Google Scholar
• Stepan, H., Wallukat, G., Schultheiss, H. P., Faber, R. & Walther, T. Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor? J. Reprod. Immunol. 73, 130–134 (2007).
  Article CAS PubMed Google Scholar
• Naccasha, N. et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am. J. Obstet. Gynecol. 185, 1118–1123 (2001).
  Article CAS PubMed Google Scholar
• Lau, S. Y. et al. Tumor necrosis factor-α, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am. J. Reprod. Immunol. 70, 412–427 (2013).
  CAS PubMed Google Scholar
• McCarthy, F. P., Kingdom, J. C., Kenny, L. C. & Walsh, S. K. Animal models of preeclampsia: uses and limitations. Placenta 32, 413–419 (2011).
  Article CAS PubMed Google Scholar
• Gervasi, M. T. et al. Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes. Am. J. Obstet. Gynecol. 185, 1124–1129 (2001).
  Article CAS PubMed Google Scholar
• Gervasi, M. T. et al. Maternal intravascular inflammation in preterm premature rupture of membranes. J. Matern. Fetal Neonatal Med. 11, 171–175 (2002).
  Article CAS PubMed Google Scholar
• Sabatier, F. et al. Neutrophil activation in preeclampsia and isolated intrauterine growth restriction. Am. J. Obstet. Gynecol. 183, 1558–1563 (2000).
  Article CAS PubMed Google Scholar
• Ogge, G. et al. Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia. J. Matern. Fetal Neonatal Med. 23, 476–487 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Roberts, J. M. et al. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161, 1200–1204 (1989).
  Article CAS PubMed Google Scholar
• Chaiworapongsa, T. et al. Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia. J. Matern. Fetal Neonatal Med. 12, 19–27 (2002).
  Article CAS PubMed Google Scholar
• Bretelle, F. et al. Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre-eclampsia. BJOG 108, 1277–1282 (2001).
  CAS PubMed Google Scholar
• Bussolino, F., Benedetto, C., Massobrio, M. & Camussi, G. Maternal vascular prostacyclin activity in pre-eclampsia. Lancet 2, 702 (1980).
  Article CAS PubMed Google Scholar
• Walsh, S. W. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am. J. Obstet. Gynecol. 152, 335–340 (1985).
  Article CAS PubMed Google Scholar
• Freedman, J. E. et al. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ. Res. 84, 1416–1421 (1999).
  Article CAS PubMed Google Scholar
• Yallampalli, C. & Garfield, R. E. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am. J. Obstet. Gynecol. 169, 1316–1320 (1993).
  Article CAS PubMed Google Scholar
• Cadroy, Y. et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br. J. Obstet. Gynaecol. 100, 416–420 (1993).
  Article CAS PubMed Google Scholar
• Chaiworapongsa, T. et al. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J. Matern. Fetal Neonatal Med. 11, 362–367 (2002).
  Article CAS PubMed Google Scholar
• Kobayashi, T., Tokunaga, N., Sugimura, M., Kanayama, N. & Terao, T. Predictive values of coagulation/fibrinolysis parameters for the termination of pregnancy complicated by severe preeclampsia. Semin. Thromb. Hemost. 27, 137–141 (2001).
  Article CAS PubMed Google Scholar
• Sharma, S. K., Philip, J., Whitten, C. W., Padakandla, U. B. & Landers, D. F. Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography. Anesthesiology 90, 385–390 (1999).
  Article CAS PubMed Google Scholar
• Fakhouri, F., Vercel, C. & Fremeaux-Bacchi, V. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin. J. Am. Soc. Nephrol. 7, 2100–2106 (2012).
  Article PubMed Google Scholar
• Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439–442 (1996).
  Article CAS PubMed Google Scholar
• Torry, D. S., Wang, H. S., Wang, T. H., Caudle, M. R. & Torry, R. J. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am. J. Obstet. Gynecol. 179, 1539–1544 (1998).
  Article CAS PubMed Google Scholar
• Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649–658 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, J. C. et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N. Engl. J. Med. 349, 427–434 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672–683 (2004).
  Article CAS PubMed Google Scholar
• Chaiworapongsa, T. et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am. J. Obstet. Gynecol. 190, 1541–1550 (2004).
  Article CAS PubMed Google Scholar
• Chaiworapongsa, T. et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J. Matern. Fetal Neonatal Med. 17, 3–18 (2005).
  Article CAS PubMed Google Scholar
• Widmer, M. et al. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet. Gynecol. 109, 168–180 (2007).
  Article CAS PubMed Google Scholar
• Romero, R. et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J. Matern. Fetal Neonatal Med. 21, 9–23 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bujold, E. et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J. Matern. Fetal Neonatal Med. 18, 9–16 (2005).
  Article CAS PubMed Google Scholar
• Maynard, S. E. et al. Gestational angiogenic biomarker patterns in high risk preeclampsia groups. Am. J. Obstet. Gynecol. 53, e1–e9 (2013).
  Google Scholar
• Wolf, M. et al. Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am. J. Obstet. Gynecol. 193, 16–22 (2005).
  Article CAS PubMed Google Scholar
• Bdolah, Y. et al. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am. J. Obstet. Gynecol. 198, 428.e1–428.e6 (2008).
  Article Google Scholar
• Cohen, A. et al. Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes. Diabetes Care 30, 375–377 (2007).
  Article CAS PubMed Google Scholar
• Levine, R. J. et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 355, 992–1005 (2006).
  Article CAS PubMed Google Scholar
• Rajakumar, A. et al. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 26, 563–573 (2005).
  Article CAS PubMed Google Scholar
• Rajakumar, A. et al. Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women. Placenta 30, 25–34 (2009).
  Article CAS PubMed Google Scholar
• Sela, S. et al. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ. Res. 102, 1566–1574 (2008).
  Article CAS PubMed Google Scholar
• Gilbert, J. S., Babcock, S. A. & Granger, J. P. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50, 1142–1147 (2007).
  Article CAS PubMed Google Scholar
• Makris, A. et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int. 71, 977–984 (2007).
  Article CAS PubMed Google Scholar
• Rajakumar, A. et al. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension 59, 256–264 (2012).
  Article CAS PubMed Google Scholar
• Lockwood, C. J. et al. Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia. Am. J. Pathol. 170, 1398–1405 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Nagamatsu, T. et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145, 4838–4845 (2004).
  Article CAS PubMed Google Scholar
• Kendall, R. L. & Thomas, K. A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl Acad. Sci. USA 90, 10705–10709 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Esser, S. et al. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140, 947–959 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Sandrim, V. C. et al. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension 52, 402–407 (2008).
  Article CAS PubMed Google Scholar
• Cindrova-Davies, T., Sanders, D. A., Burton, G. J. & Charnock-Jones, D. S. Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling. Cardiovasc. Res. 89, 671–679 (2011).
  Article CAS PubMed Google Scholar
• Eremina, V. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707–716 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Craici, I. M. et al. Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension 61, 1289–1296 (2013).
  Article CAS PubMed Google Scholar
• Chen, G. et al. Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia. Reprod. Sci. 20, 579–588 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Venkatesha, S. et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12, 642–649 (2006).
  Article CAS PubMed Google Scholar
• McAllister, K. A. et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8, 345–351 (1994).
  Article CAS PubMed Google Scholar
• Li, D. Y. et al. Defective angiogenesis in mice lacking endoglin. Science 284, 1534–1537 (1999).
  Article CAS PubMed Google Scholar
• Reimer, T. et al. Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis. J. Matern. Fetal Neonatal Med. 26, 263–269 (2013).
  Article CAS PubMed Google Scholar
• Young, B. et al. The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J. Matern. Fetal Neonatal Med. 23, 366–370 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Chaiworapongsa, T. et al. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J. Matern. Fetal Neonatal Med. 21, 25–40 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chaiworapongsa, T. et al. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study. J. Matern. Fetal Neonatal Med. 22, 1122–1139 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Romero, R. et al. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study. J. Matern. Fetal Neonatal Med. 23, 1384–1399 (2010).
  Article PubMed PubMed Central Google Scholar
• Chaiworapongsa, T. et al. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am. J. Obstet. Gynecol. 208, 287.e1–287.e15 (2013).
  Article CAS Google Scholar
• Whitten, A. E. et al. Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death. Am. J. Obstet. Gynecol. 208, 310.e1–310.e11 (2013).
  Article CAS Google Scholar
• Muttukrishna, S. et al. Soluble Flt-1 and PlGF: new markers of early pregnancy loss? PLoS ONE 6, e18041 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Signore, C. et al. Circulating angiogenic factors and placental abruption. Obstet. Gynecol. 108, 338–344 (2006).
  Article CAS PubMed Google Scholar
• Koga, K. et al. Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole. Fertil. Steril. 94, 305–308 (2010).
  Article CAS PubMed Google Scholar
• Bdolah, Y. et al. Circulating angiogenic proteins in trisomy 13. Am. J. Obstet. Gynecol. 194, 239–245 (2006).
  Article CAS PubMed Google Scholar
• Kusanovic, J. P. et al. Twin-to-twin transfusion syndrome: an antiangiogenic state? Am. J. Obstet. Gynecol. 198, 382.e1–382.e8 (2008).
  Article Google Scholar
• Romero, R. The child is the father of the man. Prenat. Neonat. Med. 1, 8–11 (1996).
  Google Scholar
• Romero, R. Prenatal medicine: the child is the father of the man. 1996. J. Matern. Fetal Neonatal Med. 22, 636–639 (2009).
  Article PubMed Google Scholar
• Fraser, S. H. & Tudehope, D. I. Neonatal neutropenia and thrombocytopenia following maternal hypertension. J. Paediatr. Child Health 32, 31–34 (1996).
  Article CAS PubMed Google Scholar
• Sarhanis, P. & Pugh, D. H. Resolution of pre-eclampsia following intrauterine death of one twin. Br. J. Obstet. Gynaecol. 99, 159–160 (1992).
  Article CAS PubMed Google Scholar
• Conde-Agudelo, A., Villar, J. & Lindheimer, M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am. J. Obstet. Gynecol. 198, 7–22 (2008).
  Article PubMed Google Scholar
• Leveno, K. J. & Cunningham, F. G. in Chesley's Hypertensive Disorders in Pregnancy (eds Lindheimer, M. D., Roberts, J. M. & Cunningham, G. C.), 389–414 (Elsevier, 2009).
  Book Google Scholar
• Saftlas, A. F., Olson, D. R., Franks, A. L., Atrash, H. K. & Pokras, R. Epidemiology of preeclampsia and eclampsia in the United States, 1979–1986. Am. J. Obstet. Gynecol. 163, 460–465 (1990).
  Article CAS PubMed Google Scholar
• Zhang, J., Zeisler, J., Hatch, M. C. & Berkowitz, G. Epidemiology of pregnancy-induced hypertension. Epidemiol. Rev. 19, 218–232 (1997).
  Article CAS PubMed Google Scholar
• Eskenazi, B., Fenster, L. & Sidney, S. A multivariate analysis of risk factors for preeclampsia. JAMA 266, 237–241 (1991).
  Article CAS PubMed Google Scholar
• Bodnar, L. M., Ness, R. B., Markovic, N. & Roberts, J. M. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann. Epidemiol. 15, 475–482 (2005).
  Article PubMed Google Scholar
• Branch, D. W., Silver, R. M., Blackwell, J. L., Reading, J. C. & Scott, J. R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet. Gynecol. 80, 614–620 (1992).
  CAS PubMed Google Scholar
• Lima, F. et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin. Exp. Rheumatol. 14, 131–136 (1996).
  CAS PubMed Google Scholar
• Lie, R. T. et al. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 316, 1343–1347 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Schieve, L. A., Handler, A., Hershow, R., Persky, V. & Davis, F. Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. Am. J. Public Health 84, 405–410 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Lisonkova, S. & Joseph, K. S. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am. J. Obstet. Gynecol. 209, 544.e541–544.e512 (2013).
  Article Google Scholar